Pharmaceutical companies face significant challenges with rising R&D costs and extended development timelines. Embracing an integrated CDMO and CRO approach that combines drug substance, drug product, clinical manufacturing, clinical research, and clinical supply chain management into one streamlined service can simplify complexity, enhance efficiency, and reduce risks, ultimately accelerating the journey from lab to market.